EDP Sciences logo
Subscriber Authentication Point
rechercher
Menu
Accueil Tous les numéros Thérapie, 62 4 (2007) 293-310 Article's citations

Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Incretins: Beyond type 2 diabetes

Paresh Dandona, Husam Ghanim and Ajay Chaudhuri
Diabetes, Obesity and Metabolism 20 (S1) 59 (2018)
https://doi.org/10.1111/dom.13153

Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition

David Goyard, Bálint Kónya, Aikaterini S. Chajistamatiou, et al.
European Journal of Medicinal Chemistry 108 444 (2016)
https://doi.org/10.1016/j.ejmech.2015.12.004

Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats

Ajaykumar N. Sharma, Ashish Pise, Jay N. Sharma and Praveen Shukla
Metabolic Brain Disease 30 (3) 659 (2015)
https://doi.org/10.1007/s11011-014-9603-7

Energy loss via urine and faeces – a combustive analysis in diabetic rats and the impact of antidiabetic treatment on body weight

R. Elvert, A. Wille, J. Wandschneider, U. Werner, H. Glombik and A. W. Herling
Diabetes, Obesity and Metabolism 15 (4) 324 (2013)
https://doi.org/10.1111/dom.12030

Prunus yedoensisMatsum. stimulates glucose uptake in L6 rat skeletal muscle cells by activating AMP-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways

Keanae Jo, Seung-Eun Lee, Sang-Won Lee and Jae-Kwan Hwang
Natural Product Research 26 (17) 1610 (2012)
https://doi.org/10.1080/14786419.2011.574133

Sodium-dependent glucose transporter protein as a potential therapeutic target for improving glycemic control in diabetes

Carmen Castaneda-Sceppa and Francisco Castaneda
Nutrition Reviews 69 (12) 720 (2011)
https://doi.org/10.1111/j.1753-4887.2011.00423.x

Personality, a key factor in personalized medicine?

Gretha J. Boersma, Lambertus Benthem, Andre P. van Beek, Gertjan van Dijk and Anton J.W. Scheurink
European Journal of Pharmacology 667 (1-3) 23 (2011)
https://doi.org/10.1016/j.ejphar.2011.05.079

Pdx-1 Regulation of the INGAP Promoter Involves Sequestration of NeuroD Into a Non-DNA-Binding Complex

David A. Taylor-Fishwick, Wenjing Shi, Laura Hughes and Aaron Vinik
Pancreas 39 (1) 64 (2010)
https://doi.org/10.1097/MPA.0b013e3181baa0cc

Neuropeptide Y is a mediator of chronic vascular and metabolic maladaptations to stress and hypernutrition

Ken Abe, Lydia Kuo and Zofia Zukowska
Experimental Biology and Medicine 235 (10) 1179 (2010)
https://doi.org/10.1258/ebm.2010.009136

New Therapeutic Agents for Diabetes Mellitus: Implications for Anesthetic Management

Daniel Chen, Stephanie L. Lee and Robert A. Peterfreund
Anesthesia & Analgesia 108 (6) 1803 (2009)
https://doi.org/10.1213/ane.0b013e31819dcc51

Sphingomyelinase dependent apoptosis following treatment of pancreatic beta-cells with amyloid peptides Aß1-42 or IAPP

Ying Zhang, Felicia Ranta, Cai Tang, et al.
Apoptosis 14 (7) 878 (2009)
https://doi.org/10.1007/s10495-009-0364-4

Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?

Martin C. Michel, Eric Fliers and Cornelis J. F. Van Noorden
Naunyn-Schmiedeberg's Archives of Pharmacology 377 (3) 205 (2008)
https://doi.org/10.1007/s00210-008-0280-0